An observational study in Stillbirth, sponsored by University of Manchester. Recruiting at 1 site in United Kingdom. Open to female participants aged 16 Years to 50 Years. Per ClinicalTrials.gov, last updated 2026-03-16.
Sponsored by University of Manchester · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 16 studies in Stillbirth with a site in United Kingdom — 4 open to participants now, 4 under way, none of them phase 3. Stillbirth · United Kingdom.
Among the 16 studies in Stillbirth with a site in United Kingdom, this one is the 9th largest by planned enrollment of the 14 observational ones that give a count, is the only one that started in 2020, is one of 14 observational ones, and was the 12th registered.
121 studies on the registry are indexed under Stillbirth; 34 are open to participants now.
Browse Stillbirth studies →4 of the 16 studies in Stillbirth with a site in United Kingdom are open now. Recruiting first, the newest first:
Medway NHS Foundation Trust · Sites in United Kingdom
Ages 16+ · Women only · Healthy volunteers
University of Manchester · Sites in United Kingdom
Ages 16–50 · Women only · Healthy volunteers
Oxford University Hospitals NHS Trust · Sites in United Kingdom
Ages 16–60 · Women only · Healthy volunteers
A study can be open while its sites in United Kingdom have not opened yet or have stopped. Only those recruiting at a site in United Kingdom →
Of the 24 Stillbirth studies recruiting now, 10 (42%) set no upper age limit and 14 (58%) stop at 75 or younger; 10 take children under 18; 10 take healthy volunteers.
This study: 16 Years to 50 Years · female · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
16 studies; the count open now beside each. This study's row is marked.
First in 1995; this study’s year is marked. 1 started in 2020.
This study's planned enrollment of 500 is close to the median of 480 across 55 observational studies indexed under Stillbirth.
Median enrollment 217,136 across the 2 interventional studies, 989 across the 14 observational. Of the 10 that completed or were terminated, 1 (10%) have results posted.
This tab as a report to print or save as PDF → With an account.
None of the 16 has an industry lead sponsor. The 9 most frequent:
University of Manchester is the lead sponsor of 201 studies on the registry; 44 are open to participants now.
University of Manchester has 6 studies filed under Stillbirth — fewer than ten, so there is no comparison to draw.
None of the studies under way reaches primary completion within a year.
Among the 16 studies in Stillbirth with a site in United Kingdom, from their registry updates:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
The death of a baby before or shortly after birth affects approximately 1 in every 250 pregnancies in the UK meaning that over 4,000 parents experience the death of a baby each year in the UK. The majority of women who have experienced the loss of a baby will have another pregnancy, usually within a year.
Our analysis of 14 studies concluded that parents need specialist support from doctors and midwives in a future pregnancy to reduce the risk of pregnancy complications and to provide the care and support they need. The Rainbow Clinic model aims to provide specialist care and support to families who have experienced the death of a baby during pregnancy or shortly afterwards. Rainbow Clinic was initially established in St Mary's Hospital, Manchester in 2013.
The Rainbow Clinic team are now working to establish Rainbow Clinics in other maternity units throughout the UK. As this is a new clinical service the investigators would like to evaluate the care provided in the Rainbow clinics across the United Kingdom, to look at women's experiences of care, their levels of anxiety and depression, to identify where care can be improved and the pregnancy outcomes of women attending Rainbow Clinic. This evaluation needs information about pregnancy outcomes and women's experiences. Participation in this research study will allow us to collect and aggregate this information. The investigators will ask all women attending participating Rainbow Clinics to complete a short questionnaire early in their pregnancy and again at the end. The study will collect information about the outcome of their pregnancy.
In the UK, 1 in 300 parents will experience a stillbirth each year, which is over 2,700 babies per year (Manktelow, Smith et al. 2016). There are also over 1,250 neonatal deaths per year, meaning there are approximately 4,000 bereaved families per year in the UK. The death of a baby before or shortly after birth is a profoundly distressing experience for women and their families and is invariably followed by a period of protracted grief (Heazell, Siassakos et al. 2016). Previous stillbirth or neonatal death is consistently recognised to increase parents' anxiety, emotional vulnerability and decrease confidence in the next pregnancy (Mills, Ricklesford et al. 2014). This is a cause for concern because studies in the general maternity population have suggested that elevated maternal anxiety increases the risk of adverse pregnancy outcomes, notably preterm birth and low birthweight (Black, Shetty et al. 2008). A recent UK longitudinal study reported that the negative psychological impacts of perinatal loss persist far beyond the next pregnancy and despite the birth of a healthy child (Blackmore et al., 2011). This may have significant long term effects on outcomes for subsequent children; previous history of stillbirth or neonatal death has been reported to disrupt maternal attachment and negatively impact on parenting (Warland, O'Leary et al. 2011). Many parents feel robbed of the 'normal' positive feelings they expected and have described to us how their subsequent pregnancies were characterised by heightened anxiety and fear (Mills, Ricklesford et al. 2014). Common misconceptions, such as the belief that a new pregnancy helps to 'get over' grief for a lost child, effectively isolates parents from social support networks, increasing reliance on external and professional intervention.
Qualitative studies of women's experiences of subsequent pregnancies highlight the value placed on regular interaction with health professionals (Côté-Arsenault, Donato et al. 2006, Côté-Arsenault 2007, Cote-Arsenault and Donato 2011). This evidence suggests that specialist antenatal support might ameliorate anxiety, improve experiences of pregnancy, support relationships and positively impact on future parenthood (Caelli, Downie et al. 2002). However, there is a dearth of evidence regarding what additional antenatal support parents' desire following a previous stillbirth or neonatal death.
To address the need for increased antenatal surveillance and support the Rainbow Clinic was established in St Mary's Hospital, Manchester in 2013 and rolled out in a neighbouring hospital in Manchester in 2016. An extensive quality improvement project and accompanying research study demonstrated that attendance at the Rainbow clinic improved pregnancy outcomes, decreased anxiety levels and was associated with a social value of £6.10 for each £1 invested. The investigators are now working to establish Rainbow Clinics in other maternity units. As this is a new clinical service there is a need to evaluate the care provided in the Rainbow clinics across the United Kingdom, to look at women's experiences of care, where care can be improved and its impact upon pregnancy outcomes for mothers and babies. This needs information about pregnancy outcomes and women's experiences. Participation in this research study will allow us to collect and aggregate this information.
Pregnant women once booked for antenatal care, will be eligible for the study if they are attending the Rainbow clinic or equivalent service at one of the recruiting sites across the country.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Women attending an antenatal service using the Rainbow Clinic model of care.
Other: Rainbow Clinic Model of Antenatal Care
Rainbow Clinic Model is an antenatal model of care with initial ultrasound scan at 23 weeks' gestation including uterine artery Doppler, frequency of subsequent scans determined using data from this initial scan. Continuity of care is provided by obstetricians and midwives.
Gestation of birth
Gestation at birth in present pregnancy
Time frame: At birth
Mode of birth
Mode of delivery in present pregnancy
Time frame: At birth
Admission to Neonatal Unit
Admission to neonatal unit following delivery of the baby
Time frame: At birth
Birthweight
Recorded weight at birth
Time frame: At birth
Maternal Anxiety
Anxiety as assessed by Generalised Anxiety Disorder (2-item) (Lowest score 0 and Highest score 6, Higher score = more anxiety) and Cambridge Worry Score (Lowest score 0 and Highest score 85, Higher score = more worry).
Time frame: 17 and 36 weeks' gestation
Maternal Depression
Depression as assessed by Edinburgh Postnatal Depression Score (Lowest score 0 and Highest Score 30, Higher score = greater depression).
Time frame: 17 and 36 weeks' gestation
Women's experience of care
Measured by bespoke patient experience questionnaire
Time frame: 36 weeks' gestation
PDFs hosted by the registry, ClinicalTrials.gov.
Plan to share: No — No IPD plan
Started Dec 2020 (actual). Primary completion is estimated for Sep 2026, 69 months after the start.
Of 30 observational studies under Stillbirth, half reached primary completion within 91 months of starting (the median), counting those still running; a quarter within 24 and three quarters within 122. This study's planned 69 months is below that.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.